CLSI EP09-A2 addresses procedures for determining the bias between two clinical methods or devices, and for the design of a method comparison experiment using split patient samples and data analysis.
The U.S. Food and Drug Administration (FDA) has evaluated and recognized this approved-level consensus guidleine for use in satisfying a regulatory requirement.
